JP2024509193A5 - - Google Patents
Info
- Publication number
- JP2024509193A5 JP2024509193A5 JP2023553584A JP2023553584A JP2024509193A5 JP 2024509193 A5 JP2024509193 A5 JP 2024509193A5 JP 2023553584 A JP2023553584 A JP 2023553584A JP 2023553584 A JP2023553584 A JP 2023553584A JP 2024509193 A5 JP2024509193 A5 JP 2024509193A5
- Authority
- JP
- Japan
- Prior art keywords
- triethylenetetramine
- manufactured article
- approximately
- dicuccinate
- article according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163157539P | 2021-03-05 | 2021-03-05 | |
| US63/157,539 | 2021-03-05 | ||
| PCT/US2022/019025 WO2022187709A1 (en) | 2021-03-05 | 2022-03-04 | Treatment of copper disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509193A JP2024509193A (ja) | 2024-02-29 |
| JP2024509193A5 true JP2024509193A5 (https=) | 2025-01-24 |
Family
ID=83115853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023553584A Pending JP2024509193A (ja) | 2021-03-05 | 2022-03-04 | 銅障害の処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20220280451A1 (https=) |
| EP (1) | EP4301350A4 (https=) |
| JP (1) | JP2024509193A (https=) |
| CN (1) | CN117157064A (https=) |
| AU (1) | AU2022231038A1 (https=) |
| CA (1) | CA3212016A1 (https=) |
| WO (1) | WO2022187709A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023255339A1 (en) * | 2022-04-19 | 2024-12-05 | Sasha A. PHILBERT | Treatment of brain copper disorders |
| CN118987254A (zh) * | 2024-08-15 | 2024-11-22 | 沈阳药科大学 | 一种基于双金属纳米点-溶瘤病毒静脉递送系统及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2875522A1 (en) * | 2002-08-20 | 2004-03-04 | Philera New Zealand Limited | Dosage forms and related therapies |
| PT1778618E (pt) * | 2004-07-19 | 2014-03-04 | Philera New Zealand Ltd | Síntese de trietilenotetraminas |
| WO2006104396A1 (en) * | 2005-03-26 | 2006-10-05 | Protemix Corporation Limited | Pre-complexed copper antagonist compositions |
| CA3018698A1 (en) * | 2005-11-09 | 2007-05-18 | Philera New Zealand Limited | Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits |
| US20090093542A1 (en) * | 2007-10-04 | 2009-04-09 | Cooper Garth J S | Copper antagonist compositions |
| WO2017049529A1 (en) * | 2015-09-24 | 2017-03-30 | Innolife Co., Ltd. | A pharmaceutical composition comprising a copper chelating tetramine and the use thereof |
| WO2017213524A1 (en) * | 2016-06-10 | 2017-12-14 | Garth Cooper | Treatment of neurodegenerative disorders |
| CA3143523A1 (en) * | 2019-06-17 | 2020-12-24 | Philera New Zealand Ltd. | Combination treatments for central nervous system disorders |
-
2022
- 2022-03-04 AU AU2022231038A patent/AU2022231038A1/en active Pending
- 2022-03-04 WO PCT/US2022/019025 patent/WO2022187709A1/en not_active Ceased
- 2022-03-04 US US17/687,525 patent/US20220280451A1/en not_active Abandoned
- 2022-03-04 EP EP22764195.8A patent/EP4301350A4/en active Pending
- 2022-03-04 CA CA3212016A patent/CA3212016A1/en active Pending
- 2022-03-04 CN CN202280025441.XA patent/CN117157064A/zh active Pending
- 2022-03-04 JP JP2023553584A patent/JP2024509193A/ja active Pending
-
2024
- 2024-08-09 US US18/799,881 patent/US20250114312A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4108980B2 (ja) | 持続放出ラノラジン製剤 | |
| US10159658B2 (en) | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk | |
| EP2273985B1 (en) | Capsule for the prevention of cardiovascular diseases | |
| JP2008069159A5 (https=) | ||
| RU2016125229A (ru) | Комбинированная система доставки с немедленным/замедленным высвобождением для лекарственных средств с коротким периодом полувыведения, в том числе для ремоглифлозина | |
| TW200948354A (en) | Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality | |
| JP2023552700A5 (https=) | ||
| WO2014011926A1 (en) | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk | |
| JP2024509193A5 (https=) | ||
| US20230346817A1 (en) | Composition and use of sglt-2 inhibitor and angiotensin receptor blockers | |
| CN105338970B (zh) | 包含他达拉非和坦洛新的药物胶囊复合制剂 | |
| WO2021129735A1 (zh) | 一种固体制剂及其制备方法和用途 | |
| CN101642444B (zh) | 单硝酸异山梨酯双速渗透泵型控释制剂及其制备方法 | |
| CN101642443B (zh) | 单硝酸异山梨酯渗透泵型控释制剂及其制备方法 | |
| CN112402392A (zh) | 一种甲磺酸达比加群酯缓释制剂及其制备方法 | |
| US11648240B2 (en) | Pharmaceutical composition comprising famotidine, lidocaine and melatonin | |
| EP0413694B1 (fr) | Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur | |
| WO2023208241A1 (zh) | 一种吡非尼酮持续性释放口服固体制剂 | |
| EP1465607B1 (fr) | Compositions pharmaceutiques a liberation modifiee | |
| US20200061053A1 (en) | Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases | |
| TR2022007384A2 (tr) | Anti̇vi̇ral etken madde i̇hti̇va eden kati dozaj formlari | |
| US20170326065A1 (en) | Methods and composition for treatment of cardiovascular conditions | |
| TR2023007202A1 (tr) | Saksagli̇pti̇n, pi̇ogli̇tazon ve bi̇r sglt-2 i̇nhi̇bi̇törü i̇çeren bi̇r farmasöti̇k formülasyon | |
| TR2023007201A1 (tr) | Vi̇ldagli̇pti̇n, metformi̇n ve bi̇r sglt-2 i̇nhi̇bi̇törü i̇çeren bi̇r farmasöti̇k formülasyon | |
| TR2022007368A2 (tr) | Anti̇vi̇ral kompozi̇syonlar |